ATE238803T1 - Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel - Google Patents

Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel

Info

Publication number
ATE238803T1
ATE238803T1 AT99966956T AT99966956T ATE238803T1 AT E238803 T1 ATE238803 T1 AT E238803T1 AT 99966956 T AT99966956 T AT 99966956T AT 99966956 T AT99966956 T AT 99966956T AT E238803 T1 ATE238803 T1 AT E238803T1
Authority
AT
Austria
Prior art keywords
proanthocyanidin
complexes
pphospholipide
antiatherosclerotic agents
phospholipids
Prior art date
Application number
AT99966956T
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE238803T1 publication Critical patent/ATE238803T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99966956T 1998-12-18 1999-12-13 Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel ATE238803T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002732A IT1304183B1 (it) 1998-12-18 1998-12-18 Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
PCT/EP1999/009854 WO2000037062A2 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents

Publications (1)

Publication Number Publication Date
ATE238803T1 true ATE238803T1 (de) 2003-05-15

Family

ID=11381268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99966956T ATE238803T1 (de) 1998-12-18 1999-12-13 Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel

Country Status (22)

Country Link
US (1) US6429202B1 (de)
EP (1) EP1140115B1 (de)
JP (1) JP4842436B2 (de)
KR (1) KR100694907B1 (de)
CN (1) CN1146429C (de)
AT (1) ATE238803T1 (de)
AU (1) AU763907B2 (de)
CA (1) CA2355776C (de)
CZ (1) CZ301495B6 (de)
DE (1) DE69907509T2 (de)
DK (1) DK1140115T3 (de)
ES (1) ES2197708T3 (de)
HK (1) HK1042430B (de)
HU (1) HU228928B1 (de)
IL (2) IL143751A0 (de)
IT (1) IT1304183B1 (de)
NO (1) NO328733B1 (de)
PL (1) PL197153B1 (de)
PT (1) PT1140115E (de)
RU (1) RU2248798C2 (de)
SK (1) SK284884B6 (de)
WO (1) WO2000037062A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507018B2 (en) * 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
CA2475630C (en) * 2002-02-12 2011-01-18 Hunza Di Pistolesi Elvira & C. S.A.S. N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
AU2005209317B2 (en) * 2004-01-28 2011-07-07 Mars, Incorporated Compositions and methods of use of A-type procyanidins
EP1837030A1 (de) 2006-03-09 2007-09-26 INDENA S.p.A. Curcumin-phospholipid-Komplexe mit verbesserter Bioverfügbarkeit
JP5443015B2 (ja) * 2008-02-19 2014-03-19 株式会社岐阜セラツク製造所 医薬組成物
IT1398624B1 (it) * 2009-02-02 2013-03-08 Dermogyn S R L Uso cosmetico della proantocianidina a2
RU2456674C1 (ru) * 2011-05-31 2012-07-20 Тагир Уралович Гафаров Способ моделирования атрофического рубца кожи
CN102688501A (zh) * 2012-06-20 2012-09-26 浙江萧山医院 原花青素b2磷脂复合物及其制备方法和用途
CN103120798A (zh) * 2013-01-10 2013-05-29 施冬云 一种具有抗氧化应激作用的磷脂复合物制备方法及其应用
CN103467778B (zh) * 2013-09-06 2015-09-30 天津大学 细菌纤维素/卵磷脂复合材料及制备和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5648377A (en) 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
FI955691A (fi) 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
WO2001019009A1 (de) 1999-09-08 2001-03-15 Siemens Aktiengesellschaft Anordnung und verfahren für eine optische informationsübertragung

Also Published As

Publication number Publication date
EP1140115B1 (de) 2003-05-02
RU2248798C2 (ru) 2005-03-27
AU763907B2 (en) 2003-08-07
ITMI982732A1 (it) 2000-06-18
ES2197708T3 (es) 2004-01-01
JP2002532543A (ja) 2002-10-02
SK8602001A3 (en) 2001-12-03
HU228928B1 (en) 2013-06-28
AU2283000A (en) 2000-07-12
JP4842436B2 (ja) 2011-12-21
EP1140115A2 (de) 2001-10-10
HUP0104665A3 (en) 2003-01-28
IT1304183B1 (it) 2001-03-08
HK1042430A1 (en) 2002-08-16
PL197153B1 (pl) 2008-03-31
NO20012944L (no) 2001-06-14
CZ20012134A3 (cs) 2001-12-12
IL143751A (en) 2006-07-05
DE69907509T2 (de) 2004-04-08
DE69907509D1 (en) 2003-06-05
HUP0104665A2 (hu) 2002-04-29
NO20012944D0 (no) 2001-06-14
CA2355776C (en) 2008-03-18
NO328733B1 (no) 2010-05-03
CN1330548A (zh) 2002-01-09
DK1140115T3 (da) 2003-08-25
SK284884B6 (sk) 2006-02-02
CN1146429C (zh) 2004-04-21
CZ301495B6 (cs) 2010-03-24
HK1042430B (zh) 2004-10-08
US6429202B1 (en) 2002-08-06
KR20010093826A (ko) 2001-10-29
WO2000037062A3 (en) 2000-08-03
KR100694907B1 (ko) 2007-03-14
PT1140115E (pt) 2003-08-29
IL143751A0 (en) 2002-04-21
CA2355776A1 (en) 2000-06-29
WO2000037062A2 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
DE69931766D1 (de) Antitumorale mittel
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
TR200100047T2 (tr) Tiyobenzimidazol türevleri
ATE212827T1 (de) Abschuppende zusammensetzung von salicylsäure und zwitterionischen verbindungen
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ATE238803T1 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
ATE218870T1 (de) Verbindungen von wirkstoffen, welche klopidogrel und antithrombotische mittel enthalten
ATE429210T1 (de) Orale flüssige zusammensetzungen
BR9909730A (pt) Dihidropirimidinas
PT902789E (pt) Derivados de androsteno
DE60121440D1 (de) Krebsbehandlung zusammensetzung, welche ein antineoplastisches mittel und pde4 inhibitor enthält
TR199802207T2 (xx) Tromboz'a kar�� kullan�lmaya mahsus pirrolidin, piperidin ve heksahidroazepin'in karboksamid t�revleri.
ATE258802T1 (de) Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln
RS11104A (en) Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
IL106237A0 (en) Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
IL139317A0 (en) Benzimdazole and benzoxazole derivatives and pharmaceutical compositions contining the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140115

Country of ref document: EP